Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-ACTB Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human ACTB |
TA349205 is a possible alternative to TA349208.
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-BDNF antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This IgG fraction antibody was prepared from rabbit antiserum after repeated immunizations with recombinant truncated human BDNF protein produced in E.coli. |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Rabbit Polyclonal Antibody against PROX1 (Center)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PROX1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 185-214 amino acids from the Central region of human PROX1. |
Goat Polyclonal Anti-VEGFR2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli. |
Goat Polyclonal Antibody against DKK1
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CDHHQASNSSRLHT, from the C Terminus of the protein sequence according to NP_036374. |
Rabbit polyclonal anti-LAMA1 antibody
| Applications | IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human LAMA1. |
Goat Polyclonal Anti-CD4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within 50 to 235 aa, corresponding to the external domain of human CD4 produced in E. coli. |
Rabbit polyclonal Neuro D (Ser274) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Neuro D around the phosphorylation site of serine 274 (P-L-SP-P-P). |
| Modifications | Phospho-specific |
Rabbit Polyclonal CD44 (Ser706) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CD44 around the phosphorylation site of Serine 706 |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CD31 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 690 aa to the C-terminus of human CD31 produced in E. coli. |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CDH1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified Recombinant peptide derived from within residues 601 to 701 of human CDH1 produced in E. coli. |
Rabbit Polyclonal Antibody against SOX2 - Embryonic Stem Cell Marker
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Sheep |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to the N-terminal region of human SOX2 protein (within residues 1-100). [Swiss-Prot# P48431] |
Rabbit polyclonal RUNX1 Antibody (S276)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This RUNX1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 227-255 amino acids from human RUNX1. |
Rabbit polyclonal KLF5 Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This KLF5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 341-370 amino acids from the C-terminal region of human KLF5. |
Rabbit Polyclonal STAT5A (Ser780) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A around the phosphorylation site of Serine 780 |
| Modifications | Phospho-specific |
Rabbit Polyclonal STAT5A/B (Ser725/730) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A/B around the phosphorylation site of Serine 725/730 |
| Modifications | Phospho-specific |
Active filters
Clonalities
- Polyclonal
Families
- ES Cell Differentiation/IPS
Availabilities
- In Stock
Filter by
Category
Target Symbol
- EGFR (26)
- AKT1 (18)
- JUN (15)
- CD44 (13)
- PDGFRB (11)
- SRC (10)
- CTNNB1 (8)
- FN1 (8)
- PRKCA (8)
- RUNX1 (8)
- STAT5A (8)
- CDH1 (7)
- GAPDH (7)
- GCG (7)
- MAPK3 (7)
- SMAD1 (7)
- BCL2L1 (6)
- CASP3 (6)
- CEBPA (6)
- MAPK8 (6)
- MYB (6)
- SMAD3 (6)
- STAT5B (6)
- TNC (6)
- ACTB (5)
- AKT2 (5)
- BCL2 (5)
- CCR5 (5)
- HNF1B (5)
- KDR (5)
- TNNI3 (5)
- CDH5 (4)
- GATA1 (4)
- GATA3 (4)
- GATA4 (4)
- GFAP (4)
- ITGA6 (4)
- KIT (4)
- PECAM1 (4)
- PTPRC (4)
- SMAD2 (4)
- SOX2 (4)
- SP1 (4)
- VCAM1 (4)
- VIM (4)
- YBX1 (4)
- ACE (3)
- ANGPT1 (3)
- BDNF (3)
- BMI1 (3)
- BSG (3)
- CD4 (3)
- CDX2 (3)
- CSF2 (3)
- CSNK1A1 (3)
- CXCR4 (3)
- HCRTR1 (3)
- ICAM1 (3)
- ID4 (3)
- ITGB3 (3)
- KLF4 (3)
- NES (3)
- NOTCH1 (3)
- PIK3CG (3)
- SERPINA1 (3)
- STAT6 (3)
- TEK (3)
- THY1 (3)
- TNFRSF8 (3)
- TUBB3 (3)
- A1BG (2)
- ABCB1 (2)
- ABCG2 (2)
- ACTN1 (2)
- ADGRE5 (2)
- AKT3 (2)
- ALDH1A1 (2)
- BGLAP (2)
- CCN3 (2)
- CD93 (2)
- CDCA4 (2)
- CDH2 (2)
- CEBPB (2)
- CSF1 (2)
- CSNK2A1 (2)
- CST3 (2)
- CYP3A4 (2)
- DHH (2)
- DKK2 (2)
- DKK4 (2)
- EGF (2)
- ENPEP (2)
- ETV1 (2)
- FAS (2)
- FCGR2A (2)
- FCGR2B (2)
- FGF18 (2)
- FGF21 (2)
- FGF7 (2)
- FLT3 (2)
Reactivities
Applications
Antibody Hosts
Conjugates
Modifications
Pathways
- Pathways in cancer (234)
- Focal adhesion (175)
- Colorectal cancer (131)
- MAPK signaling pathway (121)
- ErbB signaling pathway (117)
- Prostate cancer (96)
- Melanoma (94)
- Regulation of actin cytoskeleton (93)
- Glioma (86)
- Pancreatic cancer (86)
- Cytokine-cytokine receptor interaction (84)
- Endometrial cancer (82)
- Adherens junction (80)
- Wnt signaling pathway (76)
- Acute myeloid leukemia (74)
- GnRH signaling pathway (74)
- Non-small cell lung cancer (71)
- Gap junction (70)
- Chronic myeloid leukemia (69)
- Neurotrophin signaling pathway (65)
- Epithelial cell signaling in Helicobacter pylori infection (64)
- Jak-STAT signaling pathway (64)
- Endocytosis (63)
- T cell receptor signaling pathway (62)
- Tight junction (60)
- VEGF signaling pathway (58)
- Small cell lung cancer (57)
- Toll-like receptor signaling pathway (57)
- Cell adhesion molecules (CAMs) (56)
- Leukocyte transendothelial migration (55)
- Fc epsilon RI signaling pathway (53)
- Fc gamma R-mediated phagocytosis (53)
- B cell receptor signaling pathway (52)
- Renal cell carcinoma (52)
- Chemokine signaling pathway (49)
- Hematopoietic cell lineage (49)
- Apoptosis (47)
- Calcium signaling pathway (47)
- Progesterone-mediated oocyte maturation (46)
- Insulin signaling pathway (45)
- TGF-beta signaling pathway (45)
- ECM-receptor interaction (44)
- Bladder cancer (42)
- Melanogenesis (39)
- mTOR signaling pathway (39)
- Natural killer cell mediated cytotoxicity (38)
- Dorso-ventral axis formation (36)
- Adipocytokine signaling pathway (34)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (34)
- Pathogenic Escherichia coli infection (33)
- Hypertrophic cardiomyopathy (HCM) (30)
- Basal cell carcinoma (27)
- Dilated cardiomyopathy (27)
- Thyroid cancer (24)
- Alzheimer's disease (23)
- Type II diabetes mellitus (22)
- Hedgehog signaling pathway (20)
- Amyotrophic lateral sclerosis (ALS) (18)
- Long-term depression (17)
- Metabolic pathways (16)
- Viral myocarditis (16)
- Long-term potentiation (15)
- Maturity onset diabetes of the young (15)
- Vascular smooth muscle contraction (15)
- NOD-like receptor signaling pathway (14)
- Axon guidance (13)
- Huntington's disease (13)
- Prion diseases (13)
- Vibrio cholerae infection (13)
- Oocyte meiosis (11)
- Phosphatidylinositol signaling system (11)
- Cell cycle (10)
- p53 signaling pathway (10)
- Notch signaling pathway (9)
- Systemic lupus erythematosus (9)
- Glycolysis / Gluconeogenesis (8)
- Primary immunodeficiency (7)
- RIG-I-like receptor signaling pathway (7)
- Autoimmune thyroid disease (6)
- Neuroactive ligand-receptor interaction (6)
- Parkinson's disease (6)
- Renin-angiotensin system (6)
- Antigen processing and presentation (5)
- Cardiac muscle contraction (5)
- Complement and coagulation cascades (5)
- Type I diabetes mellitus (5)
- ABC transporters (4)
- Allograft rejection (4)
- Retinol metabolism (4)
- Graft-versus-host disease (3)
- Inositol phosphate metabolism (3)
- Tyrosine metabolism (3)
- Cysteine and methionine metabolism (2)
- Drug metabolism - cytochrome P450 (2)
- Drug metabolism - other enzymes (2)
- Linoleic acid metabolism (2)
- Lysosome (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Phenylalanine (2)
- Phenylalanine metabolism (2)
- Regulation of autophagy (2)
- Ubiquinone and other terpenoid-quinone biosynthesis (2)
- tyrosine and tryptophan biosynthesis (2)
- Asthma (1)
- Citrate cycle (TCA cycle) (1)
- Glutathione metabolism (1)
- PPAR signaling pathway (1)
- Pyruvate metabolism (1)
- Ubiquitin mediated proteolysis (1)